Baidu
map

Clin J Am Soc Nephrol: 澳研究:保持健康饮食习惯,可预防30%慢性肾病

2019-09-26 卢芳 中国循环杂志

澳大利亚邦德大学学者对15项研究63万余成年人进行的荟萃分析显示,保持健康饮食习惯有助于预防慢性肾病。

澳大利亚邦德大学学者对15项研究63万余成年人进行的荟萃分析显示,保持健康饮食习惯有助于预防慢性肾病。

这里的健康饮食指以蔬菜、水果、豆类、全谷类、鱼类和低脂奶制品等摄入较多;不健康饮食指红肉和加工肉类、钠和含糖饮料等摄入多。

研究显示,保持健康的饮食习惯,可降低30%慢性肾病风险,23%的白蛋白尿风险,不过没有观察到与估算肾小球滤过率的下降有显着相关性。



研究者指出,健康饮食的时机可能最为关键,改善饮食对于健康人群预防慢性肾病可能比已经有慢性肾病患者预防终末期肾病更有效。

还有学者眼光投向青少年,认为,应该多一点有关儿童、青少年的相关数据。

这项分析共纳入了15项前瞻性队列研究630108位参与试验时无慢性肾病成年人,平均估算肾小球滤过率为87.2 mL /(min · 1.73m2)。平均随访10.4年。

原始出处:Bach KE, et al. Healthy Dietary Patterns and Incidence of CKD: A Meta-Analysis of Cohort Studies. Clin J Am Soc Nephrol.  September 2019.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241047, encodeId=02ed124104e99, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Thu Aug 25 23:32:01 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927078, encodeId=58fa192e07888, content=<a href='/topic/show?id=629c1012246f' target=_blank style='color:#2F92EE;'>#饮食习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101224, encryptionId=629c1012246f, topicName=饮食习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Mon May 11 03:23:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373245, encodeId=058c3e324503, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Sep 27 05:34:42 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373207, encodeId=cb283e320786, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Sep 26 06:52:40 CST 2019, time=2019-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373204, encodeId=5ccd3e32044b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Sep 26 06:12:07 CST 2019, time=2019-09-26, status=1, ipAttribution=)]
    2022-08-25 12192b1am98暂无昵称

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241047, encodeId=02ed124104e99, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Thu Aug 25 23:32:01 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927078, encodeId=58fa192e07888, content=<a href='/topic/show?id=629c1012246f' target=_blank style='color:#2F92EE;'>#饮食习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101224, encryptionId=629c1012246f, topicName=饮食习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Mon May 11 03:23:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373245, encodeId=058c3e324503, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Sep 27 05:34:42 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373207, encodeId=cb283e320786, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Sep 26 06:52:40 CST 2019, time=2019-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373204, encodeId=5ccd3e32044b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Sep 26 06:12:07 CST 2019, time=2019-09-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1241047, encodeId=02ed124104e99, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Thu Aug 25 23:32:01 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927078, encodeId=58fa192e07888, content=<a href='/topic/show?id=629c1012246f' target=_blank style='color:#2F92EE;'>#饮食习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101224, encryptionId=629c1012246f, topicName=饮食习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Mon May 11 03:23:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373245, encodeId=058c3e324503, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Sep 27 05:34:42 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373207, encodeId=cb283e320786, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Sep 26 06:52:40 CST 2019, time=2019-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373204, encodeId=5ccd3e32044b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Sep 26 06:12:07 CST 2019, time=2019-09-26, status=1, ipAttribution=)]
    2019-09-27 yjs木玉

    好好好好好好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241047, encodeId=02ed124104e99, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Thu Aug 25 23:32:01 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927078, encodeId=58fa192e07888, content=<a href='/topic/show?id=629c1012246f' target=_blank style='color:#2F92EE;'>#饮食习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101224, encryptionId=629c1012246f, topicName=饮食习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Mon May 11 03:23:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373245, encodeId=058c3e324503, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Sep 27 05:34:42 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373207, encodeId=cb283e320786, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Sep 26 06:52:40 CST 2019, time=2019-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373204, encodeId=5ccd3e32044b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Sep 26 06:12:07 CST 2019, time=2019-09-26, status=1, ipAttribution=)]
    2019-09-26 txqjm

    谢谢了,学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241047, encodeId=02ed124104e99, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a272265480, createdName=12192b1am98暂无昵称, createdTime=Thu Aug 25 23:32:01 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927078, encodeId=58fa192e07888, content=<a href='/topic/show?id=629c1012246f' target=_blank style='color:#2F92EE;'>#饮食习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101224, encryptionId=629c1012246f, topicName=饮食习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Mon May 11 03:23:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373245, encodeId=058c3e324503, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Sep 27 05:34:42 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373207, encodeId=cb283e320786, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Sep 26 06:52:40 CST 2019, time=2019-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373204, encodeId=5ccd3e32044b, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Sep 26 06:12:07 CST 2019, time=2019-09-26, status=1, ipAttribution=)]

相关资讯

NEJM:Roxadustat治疗慢性肾病透析患者贫血

研究认为,对于接受透析的慢性肾病患者,Roxadustat治疗贫血的效果与Epoetin-Alfa相当

陈楠教授:NEJM中国之声,改善慢性肾病患者贫血现状!Fabry病的临床诊断需注意什么?

9月21日,中华医学会肾脏病学分会2019年学术年会已步入尾声,而在此次会议的最后一天,上海交通大学医学院附属瑞金医院的陈楠教授以“新英格兰中国之声”为主题,进行了一场精彩的讲演。小编就该场专题汇报及前两天陈楠教授的《Fabry病诊治进展》专题,为大家带来现场报道。

Circulation:APOL1风险等位基因与心血管疾病的相关性

约13%的黑种人携带2个拷贝的载脂蛋白L1(APOL1)风险等位基因G1或G2,与慢性肾病风险增加1.5-2.5倍相关。关于APOL1风险等位基因与心血管疾病(CVD)之间是否存在独立于APOL1对肾脏疾病的影响之外的关联,一直存在相互矛盾的报道。现研究人员对APOL1 G1/G2等位基因与黑人冠状动脉疾病、外周血管病和卒中的相关性进行评估。研究人员对电子健康病例进行回顾性分析。主要暴露是APOL

Radiology:个性化治疗合并慢性肾病的小肾脏肿瘤更有益处!

本研究旨在根据不同死亡原因竞合,比较个性化治疗小肾肿瘤与常规部分肿瘤切除术(PN)的有效性。

Circulation:卡格列净显著降低2型糖尿病和慢性肾病患者的心血管事件和肾衰竭风险

卡格列净可降低2型糖尿病和慢性肾病患者肾功能衰竭的风险,但对特定心血管预后的影响尚不明确,对未患有心血管疾病的个体(一级预防)的影响就更不明确了。CREDENCE试验,招募了4401位2型糖尿病和慢性肾病患者,将其随机分至卡格列净或安慰剂组。一级预防的参与者(2181位,49.6%),与二级预防的个体(2220位,50.4%)相比,更为年轻(61岁 vs 65岁),更多的女性(37% vs 31%

FDA授予AstraZeneca糖尿病药物达格列嗪治疗慢性肾病的快速指定

阿斯利康宣布FDA批准其口服、每日一次的SGLT2抑制剂Farxiga(达格列嗪)的快速通道指定,以延缓肾功能衰竭的进展,预防慢性肾病患者的心血管(CV)和肾脏死亡( CKD)。

Baidu
map
Baidu
map
Baidu
map